← All resources Sem 5 · Problem Answers

Intellectual Property Rights-I — Practical Problem Answers

Unit 1 — Introduction and Patents

7 problems from past KSLU papers. Click any question to view the full FILAD answer.

P1 A and B file patent applications with provisional specifications on the same date for the same invention. A files his complete specification much earlier than B, both within time. Examine the status of the two applications.
Primary Problem: ‘A’ and ‘B’ filed for patent application with provisional specification on the same date for the same invention. After that ‘A’ filed complete specification much earlier than ‘B’ but both filed within time allowed. Examine the status of patent application filed by both ‘A’ and ‘B’.
📋 Where this appeared in past KSLU papers:
  • Dec 2017: Q.9(c) — this problem

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • A and B filed provisional specifications for the same invention on the same date.
  • A filed his complete specification earlier than B, and both within the permitted time.

2. Issues Involved

  • Does the earlier filing of the complete specification give A priority over B?
  • What is the status of the two applications?

3. Relevant Statutory Provisions

  • Section 9, Patents Act, 1970: a provisional specification may be followed by a complete specification within twelve months (extendable by three months); failing which the application is deemed abandoned.
  • Section 11: the priority date of a claim in a complete specification is the date of filing of the application and of the provisional specification, where the claims are fairly based on it.
  • Sections 13 and 18: the examiner searches for prior claims; where the invention is claimed in another application, the Controller may require reference to it to be made; Section 25(1)(c) and 64(1)(a): only a claim with an earlier priority date defeats a later one.

4. Legal Principles & Judicial Rule

  • India follows the first-to-file system based on the priority date, which is the date of the (provisional) application, not the date of filing the complete specification.
  • A and B filed on the same date, so they have the same priority date. Neither has an earlier priority date, and the order in which the complete specifications are filed within the permitted period gives A no preference.

5. Application to the Present Problem

  • Both applications are valid, and each has the common priority date, because each filed the complete specification within the time allowed under Section 9.
  • A cannot claim priority because he filed the complete specification earlier: priority runs from the provisional filing date, which is identical.
  • Since only one valid patent can be granted for the same invention to the true and first inventor, the Controller will examine both, require reference to the other application and decide on the facts who is the true and first inventor.

6. Decision / Conclusion

Both applications are valid and have the same priority date. A gets no priority merely because his complete specification was filed earlier. The Controller will deal with the overlapping claims, and, if both claim the same invention, will determine the true and first inventor before a patent is granted.

Ratio Decidendi: Priority is determined by the date of the first (provisional) application, not by the date of the complete specification; applicants filing on the same date have equal priority.
P2 Mr. X invents an antivirus software named ‘Quick Heal’ to protect computer systems and applies for a patent. Advise him.
Primary Problem: Mr. ‘X’ invented an antivirus software namely ‘Quick Heal’ to provide protection to the computer system. He has applied for patent protection for his invention. Advise him.
📋 Where this appeared in past KSLU papers:
  • Dec 2018: Q.9(a) — this problem
  • Jul 2018 / Apr 2021: Q.6 — essay on patenting of software; Q.7(b) short note on copyright in micro-software

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • X invented antivirus software, ‘Quick Heal’, to protect computer systems.
  • He has applied for a patent.

2. Issues Involved

  • Is a computer programme patentable under the Patents Act?

3. Relevant Statutory Provisions

  • Section 3(k), Patents Act, 1970: a mathematical or business method or a computer programme per se or algorithms is not an invention.
  • Guidelines for Examination of Computer Related Inventions (2017): a software invention that shows a technical effect or technical contribution, or is combined with hardware, is not a ‘computer programme per se’ and may be patented.
  • Section 2(1)(j): the invention must be new, involve an inventive step and be capable of industrial application.
  • Section 2(o), Copyright Act, 1957: computer programmes are protected as literary works.

4. Legal Principles & Judicial Rule

  • Software as such is excluded, but if it solves a technical problem or has a technical effect it can be patented — Ferid Allani v. Union of India (2019, Delhi HC).
  • Copyright protects the code (the expression), while a patent protects the technical solution.

5. Application to the Present Problem

  • Antivirus software detects and removes malicious programs and protects the computer, which is a technical effect on the working of the computer system.
  • If X claims only a programme as such, the application is likely to be refused under Section 3(k). If he claims the method with its technical effect, and shows novelty and inventive step, it can be allowed.
  • In any event, X should protect the source code by copyright and the name by trade mark.

6. Decision / Conclusion

X should draft his claims to show the technical effect of the software (how it detects and removes threats on the computer system) and not claim the program per se. On that footing, the patent can be considered under the CRI Guidelines; otherwise Section 3(k) bars it. He should also rely on copyright for the code.

Ratio Decidendi: A computer programme per se is not patentable (Section 3(k)); software showing a technical effect or technical contribution can be.
P3 A co-owner of a patented article assigns his share to a third party without the consent of the other co-owner. Decide the validity of the assignment.
Primary Problem: The co-owner of the patented Article assigns his share in it to a third party without the consent of the other co-owner. Decide the validity of the assignment.
📋 Where this appeared in past KSLU papers:
  • Jul 2017: Q.9(b) — this problem
  • Jul 2019: Q.8(a) — short note: transfer of patent rights

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • A patent is held by two or more co-owners.
  • One co-owner assigns his share to a third party without the other’s consent.

2. Issues Involved

  • Can a co-owner of a patent assign his share without the consent of the other co-owner?

3. Relevant Statutory Provisions

  • Section 50, Patents Act, 1970: where a patent is granted to two or more persons, each is, unless there is an agreement to the contrary, entitled to an equal undivided share. Subject to any agreement, each co-owner may use the invention for his own benefit without accounting to the others, but a co-owner shall not grant a licence or assign his share without the consent of the other co-owner(s).
  • Section 68: an assignment must be in writing and registered to be effective.

4. Legal Principles & Judicial Rule

  • The restriction in Section 50 protects the co-owners from having a stranger imposed on them, and from dilution of the value of the patent. The consent of every co-owner is a statutory condition for an assignment or licence of a share.

5. Application to the Present Problem

  • The assignment was made without the other co-owner’s consent, and so did not satisfy the condition in Section 50.
  • The third party does not acquire rights that bind the other co-owner, unless there is an agreement to the contrary between the co-owners.

6. Decision / Conclusion

The assignment is not valid, since a co-owner cannot assign his share without the consent of the other co-owner (Section 50), unless the co-owners have an agreement permitting it.

Ratio Decidendi: Under Section 50, a patent co-owner may not assign or license his share without the consent of the other co-owners.
P4 An American company holds a patent for a medicine that cures AIDS/HIV, which is not available in India. The Indian Government permits an Indian company to make a generic version without the American company’s consent. Is this infringement?
Primary Problem: An American pharmaceutical company obtains patent for its invention of Medicine which cures AIDS/HIV+. The medicine is not available to the people of India. Indian Government gives permission to the Indian pharmaceutical company to produce generic version of the same invention without the consent of American company. Whether there is any infringement of the patent by Indian company? Give reasons.
📋 Where this appeared in past KSLU papers:
  • Jul 2018: Q.9(b) — this problem

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • A foreign company holds an Indian patent for an AIDS/HIV medicine.
  • The medicine is not available to people in India.
  • The Government allows an Indian company to produce a generic version without the patentee’s consent.

2. Issues Involved

  • Is production by the Indian company under Government permission an infringement?

3. Relevant Statutory Provisions

  • Section 84, Patents Act, 1970: compulsory licence on application after three years, where the reasonable requirements of the public are not satisfied, the invention is not available at a reasonably affordable price, or it is not worked in India.
  • Section 92: where the Central Government is satisfied of a national emergency, extreme urgency or public non-commercial use, it may notify it, and the Controller grants a compulsory licence.
  • Sections 99–103: use of inventions for the purposes of Government; Section 47(4): the patent is granted subject to the condition that the Government may import or make the invention for its own use.
  • TRIPS Article 31 and the Doha Declaration (2001): permit compulsory licensing to protect public health.

4. Legal Principles & Judicial Rule

  • The patentee’s monopoly is not absolute; the Act balances it against public interest, especially public health. Production under a compulsory licence or for Government use is authorised by statute and is not infringement — see Bayer Corporation v. Union of India (2014, Bombay HC) on India’s first compulsory licence (Nexavar).

5. Application to the Present Problem

  • The medicine is not available to the Indian public, and AIDS is a serious public health problem, so grounds under Sections 84 and 92 (and Government use under Section 100) are made out.
  • The Indian company is acting under the authority of the State and the statute, and not as an ordinary infringer.
  • The patentee is entitled to reasonable royalty or compensation, but cannot treat the production as infringement.

6. Decision / Conclusion

There is no infringement, provided the permission is given in accordance with the Patents Act, through a compulsory licence (Sections 84 or 92) or Government use (Chapter XVII). The patentee is entitled only to a reasonable royalty fixed by the Controller.

Ratio Decidendi: Production under a compulsory licence or for Government use authorised by the Patents Act is not infringement; the patentee gets a royalty.
P5 Tech-illa claims a machine which, if used as directed, can make a pebble hang in the air 50 feet above the earth’s surface. Can the Controller grant him a patent?
Primary Problem: Tech-illa, a maverick, claims he has invented a machine that, if used as directed, can enable a pebble to be suspended in the air at a height of 50 feet above the earth’s surface. Can the controller consider this claim for granting a patent?
📋 Where this appeared in past KSLU papers:
  • Jul 2019: Q.9(b) — this problem

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • Tech-illa claims a machine that suspends a pebble in the air 50 feet above the ground.

2. Issues Involved

  • Is the claim a patentable ‘invention’, or is it excluded by Section 3?

3. Relevant Statutory Provisions

  • Section 2(1)(j): an invention must be a new product or process involving an inventive step and capable of industrial application.
  • Section 3(a): an invention which is frivolous or which claims anything obviously contrary to well established natural laws is not an invention within the meaning of the Act.
  • Section 15: the Controller may refuse an application which does not comply with the Act.

4. Legal Principles & Judicial Rule

  • A claim that defies established laws of nature, such as gravity, without a demonstrated and credible mechanism, is treated as frivolous or non-enabling, and cannot be patented.
  • The invention must be capable of industrial application, meaning that it can actually be made or used, and the specification must enable a skilled person to do so.

5. Application to the Present Problem

  • Suspending a pebble in mid-air at 50 feet, with no stated support or force, appears contrary to the established law of gravitation.
  • The claim is in the nature of a perpetual-motion or levitation claim, and unless Tech-illa can show a plausible and working mechanism (for example, a known force like magnetism), it is frivolous.
  • The Controller can refuse the claim under Section 3(a), and also for lack of industrial applicability.

6. Decision / Conclusion

The Controller can refuse the claim under Section 3(a) as being contrary to well-established natural laws (and as not capable of industrial application), unless Tech-illa demonstrates a genuine, working and scientifically explained mechanism.

Ratio Decidendi: Claims obviously contrary to well-established natural laws are not inventions and are refused under Section 3(a).
P6 Anand obtains an Indian patent for a gene therapy invention. Six months later Maggie, a US citizen, says she obtained a US patent on the same invention two years before the grant to Anand, and wants his patent revoked. Can she succeed?
Primary Problem: Anand successfully claims and obtains a patent in India for his invention in the field of gene therapy. Around six months subsequent to the same, Maggie, a U.S. citizen, contends that she has acquired a U.S. patent on the same invention two years prior to the grant of patent to Anand. She wants Anand’s patent to be revoked. Can she succeed?
📋 Where this appeared in past KSLU papers:
  • Jul 2019: Q.9(c) — this problem
  • Jul 2019: Q.7 — essay: grounds for revocation of a patent

Marks: 10 (Q.9 — any two of three) · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • Anand holds an Indian patent for a gene therapy invention.
  • Maggie claims a US patent on the same invention, granted two years before the grant to Anand.
  • She seeks revocation of Anand’s Indian patent.

2. Issues Involved

  • Is an earlier foreign patent a ground for revocation of an Indian patent?
  • What procedure can Maggie use?

3. Relevant Statutory Provisions

  • Section 64(1), Patents Act, 1970: a patent may be revoked on a petition by any person interested on grounds including that the invention was not new having regard to what was publicly known or used in India before the priority date, or published in India or elsewhere in any document before that date (clause (e)); lack of inventive step; and that it is not an invention (clause (d)).
  • Section 25(2): post-grant opposition within one year from the publication of the grant, by any person interested.
  • Section 3(i): any process for the medicinal, surgical or curative treatment of human beings is not an invention.

4. Legal Principles & Judicial Rule

  • Patents are territorial. A US patent does not, by itself, invalidate an Indian patent. But the publication of the US patent anywhere in the world, before the priority date of Anand’s application, destroys novelty.
  • What counts is the date of Anand’s priority (filing) date, not the date of grant. The US patent being granted two years before the Indian grant is not enough, because the Indian filing date may be earlier.

5. Application to the Present Problem

  • Maggie must show that her US patent (or its publication) was published before Anand’s priority date, and that it discloses the same invention. If so, Anand’s invention is not new, and the Indian patent is liable to be revoked under Section 64(1).
  • If Anand’s Indian application was filed earlier than the US publication, the US patent is no prior art, and Maggie’s claim fails.
  • She may file a post-grant opposition under Section 25(2) (within one year of publication of grant, which is available as the grant was six months ago) or a revocation petition before the High Court under Section 64.

6. Decision / Conclusion

Maggie can succeed only if her US patent was published before Anand’s priority date and discloses the same invention, since that destroys novelty. The mere fact that her patent was granted earlier than Anand’s Indian grant is not enough. She should file a post-grant opposition under Section 25(2) or a revocation petition under Section 64.

Ratio Decidendi: An earlier publication anywhere in the world, before the priority date, anticipates an invention and is a ground for revocation; the date of grant is irrelevant.
P7 A petitioner challenges Section 126 of the Patents Act as unconstitutional under Article 19(1)(g), because it does not permit advocates to practise before the Patent Office. Decide.
Primary Problem: A petitioner challenges Section 126 of Patent Act as unconstitutional on the ground that it goes against Article 19(1)(g) of the Constitution of India as the said Section does not permit advocates to carry-out patent practice. Decide.
📋 Where this appeared in past KSLU papers:
  • Apr 2021: Q.1(b) — this problem
  • Dec 2018: Q.8(c) — short note: patent agent

Marks: 6 · Method: FILAD (Facts → Issues → Law → Application → Decision)

1. Facts of the Problem

  • Section 126 prescribes the qualifications for registration as a patent agent.
  • An advocate challenges it, saying that it denies advocates the right to do patent practice, violating Article 19(1)(g).

2. Issues Involved

  • Is a qualification requirement for patent agents a reasonable restriction on the right to practise a profession?

3. Relevant Statutory Provisions

  • Article 19(1)(g): all citizens have the right to practise any profession, or to carry on any occupation, trade or business.
  • Article 19(6): the State may impose reasonable restrictions in the interests of the general public, including the prescription of professional or technical qualifications necessary for practising any profession.
  • Section 126, Patents Act, 1970: a person is qualified to be registered as a patent agent if he is an Indian citizen, has completed 21 years, holds a degree in science, engineering or technology, and has passed the qualifying examination.
  • Section 30, Advocates Act, 1961: the general right of advocates to practise, subject to the provisions of the Act.

4. Legal Principles & Judicial Rule

  • The right to practise a profession is subject to reasonable restrictions, including the prescription of qualifications. A restriction is reasonable if it has a rational connection with the object, and is not excessive — Chintaman Rao v. State of M.P. (AIR 1951 SC 118).
  • A special statute, the Patents Act, prevails over the general Advocates Act in its own field.

5. Application to the Present Problem

  • Preparing and prosecuting patent applications requires scientific and technical knowledge, which a law degree does not provide.
  • A qualification requirement of a degree in science or engineering, with a qualifying exam, is a reasonable restriction in the interests of those who seek patent services.
  • Advocates are not barred from the litigation side, such as appearing in court in infringement or revocation matters, and may become patent agents if they have the technical qualification.

6. Decision / Conclusion

The challenge is likely to fail. Section 126 is a reasonable restriction under Article 19(6), because it prescribes technical qualifications for patent practice, and it does not violate Article 19(1)(g).

Ratio Decidendi: Prescribing technical qualifications for a specialised profession is a reasonable restriction under Article 19(6).
Share on WhatsApp